Latest Pharma Insights
FDA Issues Revised Draft Guidance On Essential Drug Delivery Performance Characteristics
Revised draft guidance from US FDA’s Office of Combination Products and its drug, device and biologics centers recommends how sponsors should identify, verify and control the system-level characteristics meant to ensure a drug-device product delivers the intended dose.
Medtech Insight - November 2, 2026
Revised draft guidance from US FDA’s Office of Combination Products and its drug, device and biologics centers recommends how sponsors should identify, verify and control the system-level characteristics meant to ensure a drug-device product delivers the intended dose.
Medtech Insight - November 2, 2026
Quick Listen: Scrip’s Five Must-Know Things
In this week's episode: US COINS Act impact; GSK’s oncology turnaround; Lilly’s KRAS push; ris-rez gives new hope in osteosarcoma; and Genmab’s latest Phase III win.
Scrip - November 2, 2026
In this week's episode: US COINS Act impact; GSK’s oncology turnaround; Lilly’s KRAS push; ris-rez gives new hope in osteosarcoma; and Genmab’s latest Phase III win.
Scrip - November 2, 2026
Quick Listen: Scrip’s Five Must-Know Things
In this week's episode: US COINS Act impact; GSK’s oncology turnaround; Lilly’s KRAS push; ris-rez gives new hope in osteosarcoma; and Genmab’s latest Phase III win.
Scrip - November 2, 2026
In this week's episode: US COINS Act impact; GSK’s oncology turnaround; Lilly’s KRAS push; ris-rez gives new hope in osteosarcoma; and Genmab’s latest Phase III win.
Scrip - November 2, 2026
FDA Issues Revised Draft Guidance On Essential Drug Delivery Performance Characteristics
Revised draft guidance from US FDA’s Office of Combination Products and its drug, device and biologics centers recommends how sponsors should identify, verify and control the system-level characteristics meant to ensure a drug-device product delivers the intended dose.
Medtech Insight - November 2, 2026
Revised draft guidance from US FDA’s Office of Combination Products and its drug, device and biologics centers recommends how sponsors should identify, verify and control the system-level characteristics meant to ensure a drug-device product delivers the intended dose.
Medtech Insight - November 2, 2026
Beauty Faces Fast-Approaching EU Deadline For New Aluminum Limits
Starting January 1, new maximum concentrations for aluminum in cosmetic products will come into effect for products sold in the EU.
HBW Insight - October 30, 2026
Starting January 1, new maximum concentrations for aluminum in cosmetic products will come into effect for products sold in the EU.
HBW Insight - October 30, 2026
Unilever’s Dove, Vaseline Led Q3 US Growth As Wellbeing Stumbled
Dove and Vaseline led Unilever’s US growth in the third quarter, but Wellbeing dragged North America down 0.7%.
HBW Insight - October 30, 2026
Dove and Vaseline led Unilever’s US growth in the third quarter, but Wellbeing dragged North America down 0.7%.
HBW Insight - October 30, 2026
What’s Next? Five Things To Look Out For In November
Generics Bulletin previews some of the most noteworthy and anticipated events on the way for the off-patent industry in November 2026.
Generics Bulletin - November 1, 2026
Generics Bulletin previews some of the most noteworthy and anticipated events on the way for the off-patent industry in November 2026.
Generics Bulletin - November 1, 2026
The Shift Toward Precision Immunology in Rheumatology Trials
How biomarker-driven strategies are reshaping patient selection, trial design and clinical development in autoimmune disease.
In Vivo - October 30, 2026
How biomarker-driven strategies are reshaping patient selection, trial design and clinical development in autoimmune disease.
In Vivo - October 30, 2026
Ophthalmology Has A Long History With AI, But Sees Modern Challenges
The AI ophthalmology market could be worth $1.3bn by 2030 as diagnosis, drug discovery and surgery all benefit from decades of innovation.
In Vivo - October 30, 2026
The AI ophthalmology market could be worth $1.3bn by 2030 as diagnosis, drug discovery and surgery all benefit from decades of innovation.
In Vivo - October 30, 2026